MARSHALL WACE, LLP - UROVANT SCIENCES LTD ownership

UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 20 filers reported holding UROVANT SCIENCES LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of UROVANT SCIENCES LTD
ValueSharesWeighting
Q4 2020$556,000
+569.9%
34,494
+547.9%
0.00%
+200.0%
Q4 2019$83,000
-87.2%
5,324
-91.8%
0.00%
-66.7%
Q1 2019$650,00064,6580.00%
Other shareholders
UROVANT SCIENCES LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 157,480$2,443,0001.17%
Wildcat Capital Management, LLC 219,975$3,412,0000.98%
Perceptive Advisors 2,406,931$37,331,0000.74%
Sio Capital Management, LLC 160,442$2,488,0000.59%
Park West Asset Management LLC 432,500$6,708,0000.28%
LVW Advisors, LLC 39,312$610,0000.14%
Baker Brothers Advisors 1,000,000$15,510,0000.08%
EcoR1 Capital, LLC 26,468$411,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 950,000$14,735,0000.04%
Alyeska Investment Group, L.P. 177,731$2,757,0000.04%
View complete list of UROVANT SCIENCES LTD shareholders